Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Sight Sciences, Inc. (SGHT) Cash Flow Statement

Sight Sciences, Inc. (SGHT) generated -$23.2M of operating cash flow over the twelve months to 2026-06-30, spent $93000 on capital expenditure and had free cash flow of -$23.3M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SGHTSight Sciences, Inc.Follow SGHT — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
495.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-52.5-76.0-47.2-22.4-29.7-23.2
Capital expenditure0.81.00.80.40.2-0.1
Free cash flow-53.4-76.9-48.0-22.7-29.9-23.3
Dividends paid0.0—0.00.00.0—
Stock-based compensation5.113.014.617.113.1—

USD millions · SEC XBRL

Sight Sciences, Inc. — questions

What is Sight Sciences, Inc.'s operating cash flow?
-$23.2M over the twelve months to 2026-06-30.
How much does Sight Sciences, Inc. spend on capital expenditure?
$93000 over the twelve months to 2026-06-30.
What is Sight Sciences, Inc.'s free cash flow?
-$23.3M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Sight Sciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.